Discontinuation report AMINOSYN II
Report ID | 20268 |
Drug Identification Number | 00742619 |
Brand name | AMINOSYN II 10% |
Common or Proper name | Aminosyn II |
Company Name | ICU MEDICAL CANADA INC |
Market Status | DORMANT |
Active Ingredient(s) | HISTIDINE TRYPTOPHAN L-LYSINE L-ALANINE METHIONINE GLYCINE L-PROLINE L-ARGININE L-VALINE L-THREONINE L-ISOLEUCINE SERINE N-ACETYL-L-TYROSINE GLUTAMIC ACID L-ASPARTIC ACID L-PHENYLALANINE L-LEUCINE |
Strength(s) | 300MG 200MG 1.05G 993MG 172MG 500MG 722MG 1.018G 500MG 400MG 1G 660MG 530MG 270MG 738MG 700MG 298MG 1G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1000ML & 2000ML |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-05-01 |
Actual discontinuation date | 2017-05-01 |
Remaining supply date | 2017-08-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-08-24 | French | Compare |
v1 | 2017-08-24 | English | Compare |
Showing 1 to 2 of 2